Antibiotic levels in lungs: key to better pneumonia treatment?

NCT ID NCT03927079

Ongoing Knowledge-focused Sponsor: Centre Hospitalier Universitaire, Amiens Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study measures how well certain antibiotics penetrate the lungs in patients with pneumonia. Researchers will compare antibiotic levels in the blood and in lung fluid from 101 adults who need a bronchoscopy. The goal is to find factors that predict good lung penetration, which could help doctors adjust antibiotic doses to improve treatment success.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: beta-lactam antibiotics (e.g., ceftriaxone, amoxicillin-clavulanic acid)
What this could lead to: If successful, this could help doctors choose the right antibiotic dose for lung infections, potentially reducing treatment failures.
What could go wrong: This is an observational study, not a treatment trial. It will not directly test a new drug or cure, and results may not change practice immediately.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIBIOTICS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pneumonia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANTIBIOTICS PNEUMONIA

Contacts and locations

Locations

CHU Amiens

Amiens, 80480, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.